Ironwood Pharmaceuticals (NASDAQ:IRWD) Now Covered by JMP Securities

JMP Securities began coverage on shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) in a research report released on Thursday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $22.00 target price on the biotechnology company’s stock. Other equities analysts also recently issued reports about the company. StockNews.com downgraded Ironwood Pharmaceuticals from a […]

Related Keywords

United States ,China ,Canada ,Mexico ,Japan ,Sravan Kumar Emany ,Banque Cantonale Vaudoise ,Ironwood Pharmaceuticals Inc ,Ironwood Pharmaceuticals Trading ,Ironwood Pharmaceuticals Company Profile ,News Ratings For Ironwood Pharmaceuticals Daily ,Securities Exchange Commission ,Goodman Advisory Group ,Financial Services Group Inc ,Ironwood Pharmaceuticals ,Free Report ,Marketbeat Ratings ,Get Free Report ,Kumar Emany ,Exchange Commission ,Advisory Group ,Services Group ,Cantonale Vaudoise ,Ironwood Pharmaceuticals Daily ,Nasdaq Irwd ,Irwd ,Medical ,46333x10 ,Initiated Coverage ,Jmp Securities ,